Home
/
ASPEN AEROGELS INC
/
Financials
/
Quarterly
ASPEN AEROGELS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ASPEN AEROGELS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$73.02M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$78.02M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$78.72M
May 8, 2025
Q3
2025
Sep 30, 2024
$117.34M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$117.77M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$94.50M
May 8, 2025
Q3
2024
Sep 30, 2023
$60.76M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$48.16M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$45.59M
May 2, 2024
Q3
2023
Sep 30, 2022
$36.71M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$45.64M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$38.41M
May 4, 2023
Q3
2022
Sep 30, 2021
$30.38M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$31.67M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$28.10M
May 10, 2022
Q3
2021
Sep 30, 2020
$24.20M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$24.64M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$28.42M
May 4, 2021
Q3
2020
Sep 30, 2019
$35.43M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$29.53M
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$23.07M
May 4, 2018
Q3
2017
Sep 30, 2017
$27.20M
Nov 3, 2017
Q2
2017
Jun 30, 2017
$25.07M
Aug 4, 2017
Q1
2018
Mar 31, 2017
$23.00M
May 4, 2018
Q3
2017
Sep 30, 2016
$29.56M
Nov 3, 2017
Q2
2017
Jun 30, 2016
$27.72M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$32.82M
May 5, 2017
Q3
2016
Sep 30, 2015
$31.54M
Nov 3, 2016
Q2
2016
Jun 30, 2015
$30.10M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$23.50M
May 6, 2016
Q3
2015
Sep 30, 2014
$25.44M
Nov 6, 2015
Q2
2015
Jun 30, 2014
$26.62M
Aug 7, 2015
Q1
2015
Mar 31, 2014
$22.36M
May 8, 2015
Q3
2014
Sep 30, 2013
$21.88M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$22.98M
Aug 8, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.33M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($9.06M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($9.06M)
Nov 6, 2025
Q3
2025
Mar 31, 2025
($301.25M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($301.25M)
May 8, 2025
Q2
2025
Mar 31, 2025
($301.25M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($12.97M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
$16.82M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$16.82M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($1.84M)
May 8, 2025
Q2
2025
Mar 31, 2024
($1.84M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($1.84M)
Nov 6, 2025
Q3
2024
Sep 30, 2023
($13.07M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($15.42M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($15.42M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($16.80M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($16.80M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($16.80M)
May 2, 2024
Q3
2023
Sep 30, 2022
($29.60M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($24.05M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.35M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($5.16M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($299.34M)
May 8, 2025
Q3
2025
Sep 30, 2024
$17.40M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$19.99M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$2.44M
May 8, 2025
Q3
2024
Sep 30, 2023
($14.63M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($17.04M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($18.91M)
May 2, 2024
Q3
2023
Sep 30, 2022
($28.31M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($22.65M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($18.62M)
May 4, 2023
Q3
2022
Sep 30, 2021
($11.50M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($6.61M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($6.18M)
May 10, 2022
Q3
2021
Sep 30, 2020
($6.70M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($5.65M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($3.09M)
May 4, 2021
Q3
2020
Sep 30, 2019
($2.15M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($5.22M)
Aug 5, 2020